2016 Annual Meeting

Endocrine Pathology Society

Room CC 606-607, March 12 2016, 7:00pm to 10:00pm

Description

Endocrine Pathology Society Meeting

Impact of Large-Scale Genomic Data on Practicing Endocrine Pathology

Saturday, March 12, 2016
7:00 PM 10:00 PM
CC 606 607

Moderators: Justine A. Barletta, MD, Harvard University Medical School, Boston, MA
Giovanni Tallini, MD, University of Bologna School of Medicine, Bologna, Italy

Course Descrition:
The Endocrine Pathology Society members determined the title, contents and speakers of this companion meeting. The target audience includes practicing pathologists, academic pathologists, pathology residents and fellows who have interests in the pathology of endocrine neoplasms.
This topic was chosen in order to present to the pathologist an updated overview of the most significant advances in the molecular analysis of thyroid, pancreatic neuroendocrine and adrenocortical tumors. Recently, many large-scale genomic papers have been published on endocrine tumors. The impact of these genomic studies on diagnosis, prognosis and therapy is considerable. The molecular data, its correlations with histopathology and the clinical features of these neoplasms will be reviewed and their influence on the daily pathology practice emphasized.

Upon completion of this educational activity, participants should be able to:

  1. Appreciate the relevance of molecular alterations in papillary thyroid carcinoma and their clinical and pathologic implications.
  2. Have an overview of the main molecular events in poorly differentiated and anaplastic thyroid carcinomas and their impact on classification, risk stratification and therapy.
  3. Update their knowledge on the novel genomic data inpancreatic neuroendocrine tumors and its implications for diagnosis and therapy.
  4. Understand the importance of genomics in the pathologic assessment of adrenocortical carcinomas.

Agenda

7:00 PM

Papillary Thyroid Carcinoma TCGA and Beyond: Impact on Thyroid Cancer Pre-operative Diagnosis, Prognostication, and Reclassification of Encapsulated Follicular Variant of Papillary Carcinoma
Yuri E. Nikiforv, MD, PhD, University of Pittsburgh, Pittsburgh, PA

7:40 PM

Genomic Landscapes of Poorly-differentiated and Anaplastic Thyroid Carcinoma: Clues for Better Classification, Risk Stratification and Therapy
Ronald Ghossein, MD, Memorial Sloan-Kettering Cancer Center, New York, NY

8:20 PM

New Genetics Data of Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies
Anja Schmitt Kurrer, MD, University of Bern, Zurich, Switzerland

9:00 PM

Genomic Appraisal of Adrenocortical Carcinomas: What Practicing Pathologists Need to Know
Thomas Giordano, MD, PhD, University of Michigan, Ann Arbor, MI

Meetings

home-circle-inset-1
view more